SUBSCRIBE
SUBSCRIBE
News   FDA

UCB, Inc. Says Keppra XR Epilepsy Drug Approved in U.S.

September 15, 2008 | 
1 min read

BRUSSELS, Sept 15 (Reuters) - Belgian pharma group UCB said on Monday that U.S. health authorities had approved epilepsy drug Keppra XR and that it would go on sale just before its mother drug loses patent protection.

FDA Approvals Europe
MORE ON THIS TOPIC
Roche's signage at its office in France
Approvals
Roche Wins First-Line Breast Cancer Nod for Oral PI3K Blocker, Projects $2.3B in Peak Sales
October 11, 2024
 · 
2 min read
 · 
Tristan Manalac
Pictured: A scientist works behind an FDA sign/Tay
FDA Tracker
Third-Party Issues Delay Zealand’s Congenital Hyperinsulinism Drug
October 10, 2024
 · 
188 min read
 · 
Heather McKenzie
Pictured: FDA Headquarters, iStock, Grandbrothers
Adcomms
Stealth’s Ultrarare Disease Candidate Might Not Meet Bar for Approval: FDA
October 9, 2024
 · 
2 min read
 · 
Tristan Manalac
A closeup of a doctor taking a blood sample from a newborn's foot
Complete response letters
Zealand Hit With CRL for Ultrarare Genetic Disease Treatment
October 9, 2024
 · 
2 min read
 · 
Tristan Manalac